SCHEMBL16975137

SCHEMBL16975137

CC(C)OC(=O)[C@H](N)CC(Cc1ccc(-c2cc(Cl)ccc2F)cc1)NC(=O)c1cc(O)no1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16930479 1.00 MME (0.66) MME
SCHEMBL16930560 0.91 MME (0.72) MME
SCHEMBL16930614 0.91 MME (0.72) MME
SCHEMBL16975177 0.88 MME (0.80) MME
SCHEMBL16930622 0.88 MME (0.80) MME
SCHEMBL16930553 0.88 MME (0.80) MME
SCHEMBL16930527 0.88 MME (0.66) MME
SCHEMBL16930536 0.81 MME (0.71) MME
SCHEMBL24350653 0.80 MME (0.60) MME
SCHEMBL16930484 0.80 MME (0.72) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099678-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-12-07 — — EP disclosed
WO-2015116786-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-06 — — WO disclosed
Send feedback